healthcare costs
Commentary
What Procedural Ethics Can Learn from the Quest for Moral Justification for the “Rule of Rescue”
Bernard Keating
Commentary
Expensive Drug Prices for Rare Cancers: Are Patients Truly Benefitting?
Kristina Jenei and Bishal Gyawali
Commentary
Can Managed Access Agreements Mitigate Evidentiary, Economic and Ethical Issues with Access to Expensive Drugs for Rare Diseases in the Canadian Context?
Melanie McPhail and Tania Bubela
The Authors Respond
Expensive Drugs for Rare Diseases in Canada: Time for Action Everywhere and by Everyone
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Eric Lun, Bob Nakagawa, Dean Regier, Shirin Rizzardo an...
Research Paper
Patent “Evergreening” of Medicine–Device Combination Products: A Global Perspective
Reed F. Beall, Tali Glazer, Haris Ahmad, Mikayla Buell, Slane Hahn, Adam R. Houston, Aaron S. Kessel...
Greening Healthcare
Identifying Opportunities for Greenhouse Gas Reductions and Cost Savings in Hospitals: A Knowledge Translation Tree
Myles Sergeant, Richard Webster, Linda Varangu, Anita Rao, Sujane Kandasamy, Madeline Rampton, Neha ...